DIA Biosimilars 2013

Articles Published in 2009

Premier Acquires Pivotal Research Centers for $5M

Tuesday, March 17, 2009 07:00 AM

Premier Research Arizona, a division of UK-based CRO Premier Research Group, finalized its deal with Pioneer Behavioral Health to acquire Pivotal Research Centers, a site management organization owned by Pioneer and specializing in phase II/IIa clinical trials.

More... »

Cenduit: Now with Patient Reminders

Criterium Opens Office in Canada

Monday, March 16, 2009 08:00 AM

U.S. contract research organizations (CROs) are often eager to expand operations into Europe, Asia and Africa, but neighboring Canada is often omitted from CROs’ plans for global expansion. Saratoga, N.Y.-based Criterium, however, is bucking that trend with the recent opening of its Toronto office.

More... »

CRF Health – eCOA Forum

JLL Partners Extends Deadline for Tender Offer of PharmaNet Shares

Friday, March 13, 2009 12:00 PM

PharmaNet Development Group stockholders have another week to tender their shares as part of the contract research organization (CRO)’s pending acquisition by private equity firm JLL Partners.

More... »

MDS Pharma's First Quarter Revenues Down 12%

Friday, March 13, 2009 08:00 AM

Revenues for contract research organization (CRO) MDS Pharma Services continue to fall as a result of client delays in late-stage research and decreased activity in preclinical and bioanalytical services.

More... »

PharmaNet Launches Clinical Trial Staffing Service

Thursday, March 12, 2009 09:00 AM

Despite a pending acquisition by private equity firm JLL Partners, contract research organization (CRO) PharmaNet continues to expand its service offerings and locations.

More... »

BASi Appoints COO, Expands Business Development Efforts

Wednesday, March 11, 2009 09:13 AM

West Lafayette, Ind.-based CRO BASi appointed Anthony Chilton, Ph.D., chief operating officer, scientific services. In this role, Chilton will oversee scientific services provided to BASi’s clients from its locations in North America and Europe.

More... »

ACM Global Central Lab Acquires Pivotal Labs

Tuesday, March 10, 2009 09:16 AM

Rochester, N.Y.-based ACM Global Central Laboratory expanded its global reach with the acquisition of York, UK-based Pivotal Laboratories, a central lab serving Europe, Israel and South Africa. Neither company provided details about the terms of the acquisition agreement. ACM and Pivotal had a long-time exclusive partnership before this deal.

More... »

UBC-CogState Partnership Short-Lived

Monday, March 9, 2009 07:29 AM

Bethesda, Md.-based contract research organization (CRO) United BioSource Corporation (UBC) has ended its partnership with cognitive testing provider CogState—just seven months after it began.

More... »

etrials Ends 'Challenging Year,' Reports $15.8M Loss

Friday, March 6, 2009 07:59 AM

In what CEO M. Denis Connaghan called a "challenging year," eClinical company etrials reported a decrease in year-end revenue and an operating loss for the year.

More... »

CenterWatch Monthly March 2009

Thursday, March 5, 2009 08:00 AM

Pharma Consolidation Slows CRO Market in Short Term

More... »

`
CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs